Yahoo Finance Today’s Research Reports on Trending Tickers: GW Pharmaceuticals and Intercept Pharmaceuticals
NEW YORK, NY / ACCESSWIRE / February 2, 2018 / Rising bond yields created mixed results on Wall Street Thursday. The S&P 500 Index declined 0.06 percent to close at 2,821.98, while the Nasdaq Composite Index fell 0.35 percent. The Dow Jones Industrial Average rose 0.14 percent to close at 26,186.71. On Thursday, the benchmark 10-year Treasury yield reached 2.784 percent and the yield on the 30-year Treasury bond surpassed 3 percent for the first time since May 2017.
RDI Initiates Coverage on:
GW Pharmaceuticals Plc.
https://rdinvesting.com/news/?ticker=GWPH
Intercept Pharmaceuticals, Inc.
https://rdinvesting.com/news/?ticker=ICPT
GW Pharmaceuticals' stock moved 1.76% lower Thursday, to close the day at $135.70. The stock recorded a trading volume of 255,575 shares, which was below its three months average volume of 407,883 shares. In the last year, GW Pharmaceuticals' shares have traded in a range of 92.65 - 143.37. The share price has gained 46.47% from its 52 week low. The company's shares are currently trading above their 200-day moving average. The stock's 50-day moving average of $133.91 is greater than its 200-day moving average of $116.25. Shares of GW Pharmaceuticals have gained roughly 2.8 percent in the past month.
Access RDI's GW Pharmaceuticals Plc. Research Report at:
https://rdinvesting.com/news/?ticker=GWPH
On Thursday, shares of Intercept Pharmaceuticals recorded a trading volume of 3,639,242 shares, which was above the three months average volume of 811,512 shares. The stock ended the day 0.14% lower at 62.01. The share price has gained 20.34% from its 52 week low with a 52 week trading range of 51.53 - 135.59. The company's shares are currently trading below their 200-day moving average. The stock's 50-day moving average of $59.82 is below its 200-day moving average of $78.70. Shares of Intercept Pharmaceuticals have gained roughly 6.16 percent in the past month.
Access RDI's Intercept Pharmaceuticals Research Report at:
https://rdinvesting.com/news/?ticker=ICPT
Our Actionable Research on GW Pharmaceuticals Plc. (NASDAQ:GWPH) and Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) can be downloaded free of charge at Research Driven Investing.
Research Driven Investing
We are committed to providing relevant and actionable information for the self-directed investor. Our research is reputed for being a leader in trusted, in-depth analysis vital for informed strategic trading decisions. The nimble investor can leverage our analysis and collective expertise to execute a disciplined approach to stock selection.
RDInvesting has not been compensated; directly or indirectly; for producing or publishing this document.
Disclaimer: This article is written by an independent contributor of RDInvesting.com and Nadia Noorani, a CFA® charter holder, has provided necessary guidance in preparing the document templates. RDInvesting.com is neither a registered broker dealer nor a registered investment advisor. For more information please read our full disclaimer at www.rdinvesting.com/disclaimer.
CONTACT
For any questions, inquiries, or comments reach out to us directly at:
Address:
Research Driven Investing, Unit #901 511 Avenue of the Americas, New York, NY, 10011
Email:
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute
SOURCE: RDInvesting.com
